Investing Profile

Martin Pfister

InvestorVC
Principal at High-Tech Gründerfonds
Photo of Martin Pfister, Principal at High-Tech Gründerfonds
New York University Network
77 CONNECTIONS
High-Tech Gründerfonds Network
12 CONNECTIONS
cb
$100K - $5.0M
$1.5M
4
CompanyStageDateRound SizeTotal Raised
GeneQuine Biotherapeutics
Series AFeb 2021$7M
$7M
OMEICOS Therapeutics
Series CNov 2018$19M
Series AApr 2015$7M
SeedDec 2013$680K
$27M
Co-investors: Holger Reithinger (Forbion)
Supervisory Board Member WM-Therapeutics2022 - Present
Member Board of Directors GeneQuine Biotherapeutics2020 - Present
Board of Directors (observer) lino Biotech AG2020 - Present
Board of Directors (Observer) OMEICOS Therapeutics GmbH2015 - Present
Venture Capital Investor High-Tech Gründerfonds2010 - Present
Board of Directors (observer) Cardior Pharmaceuticals2021 - 2022
Member Board of Directors JeNaCell GmbH2017 - 2021
Member Board of Directors Biametrics GmbH2016 - 2020
Founder, Partner dii - an Economist Intelligence Unit - Healthcare business2004 - 2018
Managing Director biosaxony2007 - 2010
Marketing & Sales Manager Roboscreen GmbH2001 - 2003
Medical Journalist (print, online, film) my media GmbH2000 - 2001
New York University School of Medicine MD PhD
Universität Leipzig Dr. rer. nat. med. Immunology
Universität Greifswald Biopharmacologist Medicine & Pharmacy